Related Experiment Video
Updated: Apr 19, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
4.6K
Intrathoracic Castleman disease
Turkish Journal of Medical Sciences
|December 25, 2014
Summary
Surgical excision is the primary method for diagnosing and treating Castleman disease, especially localized forms. Complete removal offers a cure, but complex cases may require multimodal therapy.
Area of Science:
- Thoracic Surgery
- Pathology
- Oncology
Background:
- Castleman disease is a rare lymphoproliferative disorder.
- Diagnosis often relies on surgical resection and histopathological examination.
- Thoracic involvement necessitates specialized surgical approaches.
Purpose of the Study:
- To analyze patients diagnosed with Castleman disease via surgery.
- To review surgical outcomes and histopathological findings.
- To evaluate the efficacy of surgical management for thoracic Castleman disease.
Main Methods:
- Retrospective analysis of postoperative pathological records from 1992-2012.
- Inclusion of 19 patients diagnosed with Castleman disease.
- Surgical procedures included thoracotomy, video-assisted thoracoscopy, and mediastinoscopy.
Main Results:
- The study included 19 patients (13 male, 6 female) with a mean age of 40.1 years.
- Hyaline vascular-type was the most common histopathological finding (n=16).
- Surgical interventions involved biopsies (n=2) and mass excisions (n=17).
Conclusions:
- Castleman disease commonly affects the mediastinum and hilum.
- Surgical excision is the preferred diagnostic and therapeutic strategy.
- Complete excision is curative for localized disease; multimodal treatment is advised for multicentric forms.
Related Concept Videos
01:26Pneumothorax-I
2.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.1K
01:27Pneumothorax-II
1.5K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.5K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
2
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
01:08Pneumothorax II: Pathophysiology
2
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
2
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
806
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
562
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
562